MAPT and Alzheimer disease: The current study expands these in vitro results by reporting for the first time that the cleavage of tau at its N-terminal projection domain releases in ICV-STZ mice the AD-relevant toxic NH2htau [38], which can contribute to aggravate the cognitive deficits by inhibiting the AKT/GSK3-β signaling.